InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: GuiNoir post# 25328

Wednesday, 10/21/2015 5:19:20 PM

Wednesday, October 21, 2015 5:19:20 PM

Post# of 461819
A couple of additional thoughts:
-targeting upstream pathology (mis-folded proteins) very likely has outcomes uncorelated to plaque removal drugs (as almost 100% of previous drugs were)..
-also since they were not targeting plaque removal they could do tests on untreated mice ...for example see if they could make old mice smarter....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News